Seelos Therapeutics
SEEL
$0.29
Share price
-6.99%
Change (1 day)
-64.57%
Change (1 year)
Categories
P/S ratio for Seelos Therapeutics (SEEL)
P/S ratio as of May 2024 (TTM): 6.05
According to Seelos Therapeutics 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 6.04547. At the end of 2023 the company had a P/S ratio of 16.8.
P/S ratio history for Seelos Therapeutics from 2002 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 16.8 | |
| 2022 | N/A | |
| 2021 | N/A | |
| 2020 | N/A | -100% |
| 2019 | 96.6 | |
| 2018 | N/A | |
| 2017 | N/A | -100% |
| 2016 | 28.2 | 173.79% |
| 2015 | 10.3 | 115.43% |
| 2014 | 4.79 | -87.92% |
| 2013 | 39.6 | 434.82% |
| 2012 | 7.41 | -71.91% |
| 2011 | 26.4 | 99.8% |
| 2010 | 13.2 | 31.41% |
| 2009 | 10.0 | 407.87% |
| 2008 | 1.98 | -97.87% |
| 2007 | 92.8 | 222.24% |
| 2006 | 28.8 | 38.02% |
| 2005 | 20.9 | -90.32% |
| 2004 | 216 | -85.08% |
| 2003 | > 1000 | 965.29% |
| 2002 | 136 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | N/A | N/A | 🇺🇸 USA |